CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience

Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy

(2020) Raffaele Ornello et al.   JOURNAL OF HEADACHE AND PAIN

Erenumab in highly therapy-refractory migraine patients: First German real-world evidence

(2020) Armin Scheffler et al.   JOURNAL OF HEADACHE AND PAIN

LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF FREMANEZUMAB IN MIGRAINE: A RANDOMIZED STUDY

(2020) Peter J. Goadsby et al.   NEUROLOGY

Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure

(2019) Dustin D Ruff et al.   CEPHALALGIA

A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine

(2018) Angelo Camporeale et al.   BMC Neurology

Galcanezumab in chronic migraine

(2018) Holland C. Detke et al.   NEUROLOGY

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

(2017) Stewart Tepper et al.   LANCET NEUROLOGY

Fremanezumab for the Preventive Treatment of Chronic Migraine

(2017) Stephen D. Silberstein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Amitriptyline in the Prophylactic Treatment of Migraine and Chronic Daily Headache

(2010) James R. Couch et al.   HEADACHE